M. Wilschanski

921 total citations
24 papers, 556 citations indexed

About

M. Wilschanski is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, M. Wilschanski has authored 24 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in M. Wilschanski's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (6 papers) and Eosinophilic Esophagitis (3 papers). M. Wilschanski is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (6 papers) and Eosinophilic Esophagitis (3 papers). M. Wilschanski collaborates with scholars based in Israel, Belgium and Netherlands. M. Wilschanski's co-authors include P. Durie, Isabelle Sermet‐Gaudelus, K. De Boeck, Paola Melotti, Jorge Amil Dias, M. Luisa Mearin, Steffen Husby, Anna Papadopoulou, Yvan Vandenplas and Simon Murch and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

M. Wilschanski

22 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wilschanski Israel 9 307 270 109 51 48 24 556
J Bellanger France 8 63 0.2× 247 0.9× 55 0.5× 35 0.7× 94 2.0× 23 398
Pierantonio Ostuni Italy 11 29 0.1× 110 0.4× 67 0.6× 52 1.0× 23 0.5× 24 312
Philip R. Faught United States 9 67 0.2× 155 0.6× 15 0.1× 33 0.6× 14 0.3× 24 326
Phillip J. Clements United States 6 121 0.4× 135 0.5× 38 0.3× 115 2.3× 63 1.3× 7 518
Marie Secaf Brazil 10 32 0.1× 83 0.3× 26 0.2× 38 0.7× 84 1.8× 24 311
Ahmed Aboumohamed United States 10 151 0.5× 220 0.8× 32 0.3× 65 1.3× 6 0.1× 32 392
Kyung Seop Lee South Korea 10 80 0.3× 95 0.4× 64 0.6× 54 1.1× 6 0.1× 34 303
Maciej Słodkowski Poland 12 83 0.3× 210 0.8× 26 0.2× 17 0.3× 51 1.1× 56 351
Minoru Horisawa Japan 14 163 0.5× 440 1.6× 16 0.1× 61 1.2× 194 4.0× 21 606
A. D. N. Scott United Kingdom 14 85 0.3× 223 0.8× 71 0.7× 19 0.4× 17 0.4× 21 447

Countries citing papers authored by M. Wilschanski

Since Specialization
Citations

This map shows the geographic impact of M. Wilschanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wilschanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wilschanski more than expected).

Fields of papers citing papers by M. Wilschanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wilschanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wilschanski. The network helps show where M. Wilschanski may publish in the future.

Co-authorship network of co-authors of M. Wilschanski

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wilschanski. A scholar is included among the top collaborators of M. Wilschanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wilschanski. M. Wilschanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sermet‐Gaudelus, Isabelle, E. Girodon, F. Vermeulen, et al.. (2022). ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction. Journal of Cystic Fibrosis. 21(6). 922–936. 23 indexed citations
2.
Sultan, Mutaz, Peri Millman, Nitzan Kol, et al.. (2022). DOP64 Pathogenic RIPK1 Mutations Cause Infantile-onset IBD with Inflammatory and Fistulizing Features. Journal of Crohn s and Colitis. 16(Supplement_1). i109–i109.
3.
4.
Biervliet, Stéphanie Van, Bruno Hauser, Stijn Verhulst, et al.. (2017). EPS3.5 Probiotics in cystic fibrosis (CF) patients: a double blind cross-over study. Journal of Cystic Fibrosis. 16. S42–S42. 1 indexed citations
5.
Bodewes, Frank A.J.A., Henkjan J. Verkade, & M. Wilschanski. (2016). Gastroenterological endpoints in drug trials for cystic fibrosis. Pediatric Pulmonology. 51(S44). S18–S22. 10 indexed citations
6.
Kerem, Eitan, M. Wilschanski, Isabelle Sermet‐Gaudelus, et al.. (2014). 94 The effect of Pseudomonas aeruginosa infection on pulmonary function outcome in a cohort of patients with nonsense mutation cystic fibrosis. Journal of Cystic Fibrosis. 13. S70–S70. 4 indexed citations
7.
Papadopoulou, Anna, Sibylle Koletzko, Robert Heuschkel, et al.. (2013). Management Guidelines of Eosinophilic Esophagitis in Childhood. Journal of Pediatric Gastroenterology and Nutrition. 58(1). 107–118. 198 indexed citations
8.
Kerem, Eitan, M. Wilschanski, Isabelle Sermet‐Gaudelus, et al.. (2013). WS7.5 Interim results of the phase 3 open-label study of ataluren in nonsense mutation cystic fibrosis (nmCF). Journal of Cystic Fibrosis. 12. S15–S15. 5 indexed citations
9.
Kerem, Eitan, M. Wilschanski, K. De Boeck, et al.. (2011). 65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data. Journal of Cystic Fibrosis. 10. S17–S17. 6 indexed citations
10.
Boeck, K. De, Nico Derichs, Isabelle Fajac, et al.. (2011). New clinical diagnostic procedures for cystic fibrosis in Europe. Journal of Cystic Fibrosis. 10. S53–S66. 83 indexed citations
11.
Bronsveld, Inez, M. Sinaasappel, Kevin W Southern, et al.. (2009). Evaluation of European protocols for measuring nasal potential differences. Journal of Cystic Fibrosis. 8. S10–S10. 2 indexed citations
12.
Werlin, Steven L., Limor Cohen, Eitan Kerem, et al.. (2008). Enteropathy – a new finding in cystic fibrosis. Journal of Cystic Fibrosis. 7. S79–S79. 1 indexed citations
13.
Wilschanski, M., S. Armoni, Yasmin Yaakov, et al.. (2008). PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF. Journal of Cystic Fibrosis. 7. S22–S22. 10 indexed citations
14.
Sermet‐Gaudelus, Isabelle, À. Munck, Bruno Hauser, et al.. (2008). Defining DIOS and constipation in cystic fibrosis: a multicenter study on the incidence characteristics and treatment of DIOS. Journal of Cystic Fibrosis. 7. S79–S79. 4 indexed citations
15.
16.
Kerem, Eitan, M. Wilschanski, Gary Elfring, et al.. (2008). Quantitative cough assessment in cystic fibrosis (CF). Journal of Cystic Fibrosis. 7. S59–S59. 1 indexed citations
17.
Wilschanski, M. & P. Durie. (2007). Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut. 56(8). 1153–1163. 125 indexed citations
18.
Kerem, Eitan, Samit Hirawat, S. Armoni, et al.. (2007). 41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study. Journal of Cystic Fibrosis. 6. S10–S10. 2 indexed citations
19.
Wilschanski, M., Yasmin Yaakov, G M Stern, et al.. (2007). 367 Intestinal current measurement as a diagnostic procedure in cystic fibrosis in infants and young children. Journal of Cystic Fibrosis. 6. S90–S90.
20.
Mussaffi, Huda, et al.. (2000). Reaching the diagnosis of cystic fibrosis--the limits of the spectrum.. PubMed. 2(2). 94–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Bellanger Breakdown of academic impact, for papers by Pierantonio Ostuni Breakdown of academic impact, for papers by Philip R. Faught Breakdown of academic impact, for papers by Phillip J. Clements Breakdown of academic impact, for papers by Marie Secaf Breakdown of academic impact, for papers by Ahmed Aboumohamed Breakdown of academic impact, for papers by Kyung Seop Lee Breakdown of academic impact, for papers by Maciej Słodkowski Breakdown of academic impact, for papers by Minoru Horisawa Breakdown of academic impact, for papers by A. D. N. Scott
Rankless by CCL
2026